ArticleBMC nephrology2026
Association of the C-reactive protein-to-albumin ratio (CAR) with clinical outcomes in chronic kidney disease patients undergoing surgery: a retrospective cohort analysis of the INSPIRE database.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo evaluate the relationship between C‑reactive protein–albumin ratio (CAR) and clinical outcomes among perioperative patients with chronic kidney disease (CKD).
methodThis study retrospectively analyzed CKD patients who underwent surgery using data from the INSPIRE database, a single-center registry of perioperative clinical, laboratory, and outcome data from adult surgical patients at Seoul National University Hospital. Patients were stratified into quartiles on the basis of their CAR upon admission. Associations between CAR and outcomes were evaluated using adjusted Cox proportional hazards models (in‑hospital and 30‑day mortality), multivariable logistic regression (ICU admission), and a generalized linear model (length of hospitalization).
resultsThe cohort comprised 2338 CKD patients, with an average age of 60.7 ± 14.8 years, and 65.8% were males. After controlling for possible confounding factors, an elevated log2-CAR was independently associated with in-hospital mortality (HR = 1.08, 95% CI 1.02–1.15; p = 0.009), with the highest quartile (Q4) showing a 1.99-fold higher risk than Q1 (p < 0.001). The secondary outcomes demonstrated similar trends: a higher CAR correlated with increased 30-day mortality (adjusted HR = 1.1, 95% CI 1.02–1.18; p = 0.012), ICU admission (adjusted OR = 1.05, 95% CI 1.01–1.09; p = 0.021) and a prolonged hospital stay (adjusted exp(β) = 1.06; 95% CI 1.05–1.08; p < 0.001). Subgroup and sensitivity analyses yielded consistent findings.
conclusionAn elevated CAR is positively associated with increased risks of in‑hospital death, 30-day mortality, ICU admission, and longer hospital stays in CKD patients who have undergone surgery. Our findings support the use of the preoperative CAR, a readily available, cost-effective marker, to inform risk stratification and guide perioperative care in patients with CKD. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.